These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7506291)

  • 1. The influence of endocrine factors on the serum concentrations of insulin-like growth factor-I (IGF-I) and IGF-binding proteins.
    Sugisaki T; Yamada T; Takamatsu K; Noguchi T
    J Endocrinol; 1993 Sep; 138(3):467-77. PubMed ID: 7506291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
    Donahue LR; Beamer WG
    J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of thyroid hormone on insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) expression in the neonatal rat: prolonged high expression of IGFBP-2 in methimazole-induced congenital hypothyroidism.
    Näntö-Salonen K; Glasscock GF; Rosenfeld RG
    Endocrinology; 1991 Nov; 129(5):2563-70. PubMed ID: 1718729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients.
    Jørgensen JO; Blum WF; Møller N; Ranke MB; Christiansen JS
    J Clin Endocrinol Metab; 1991 Mar; 72(3):582-7. PubMed ID: 1705258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I.
    Camacho-Hubner C; Clemmons DR; D'Ercole AJ
    Endocrinology; 1991 Sep; 129(3):1201-6. PubMed ID: 1714829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
    van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
    J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) regulation of circulating insulin-like growth factor-I levels during sexual maturation of the GH-deficient dwarf (dw/dw) male rat.
    Crawford BA; Dobbie P; Bass JJ; Lewitt MS; Baxter RC; Handelsman DJ
    J Endocrinol; 1994 Jun; 141(3):393-401. PubMed ID: 7520929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-I and IGF-binding protein-3 in plasma of GH-deficient rats.
    Butler AA; Gallaher BW; Ambler GR; Gluckman PD; Breier BH
    J Endocrinol; 1996 Jul; 150(1):67-76. PubMed ID: 8708564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity.
    Kanety H; Karasik A; Klinger B; Silbergeld A; Laron Z
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):144-9. PubMed ID: 7680834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of metabolic water and protein compartments by insulin-like growth factor-I and testosterone in growth hormone-deficient lit/lit mice.
    Donahue LR; Watson G; Beamer WG
    J Endocrinol; 1993 Dec; 139(3):431-9. PubMed ID: 7510770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.